share_log

TCR2 Therapeutics Q1 EPS $(1.03) Down From $(0.76) YoY

Benzinga ·  May 11, 2023 06:46

TCR2 Therapeutics (NASDAQ:TCRR) reported quarterly losses of $(1.03) per share. This is a 35.53 percent decrease over losses of $(0.76) per share from the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment